Datadog (DDOG) earnings call: saw a reduction in usage from largest customer, which led to the de-risked guidance; "business is booming"
Newsquawk Staff ·
Datadog (DDOG) earnings call: saw a reduction in usage from largest customer, which led to the de-risked guidance; "business is booming"
What it means
Usage-based software names have a well-worn pattern here: consumption from the largest customers flexes with optimization cycles, and a single outsized client pulling back has historically been enough to force guidance resets even when the rest of the book is growing. The distinction that matters is between an idiosyncratic concentration issue at one account and a broader slowdown in consumption across the cohort, since the former tends to be digested as a one-off while the latter re-rates the whole usage-based peer group. Management pairing the disclosure with 'business is booming' rhetoric follows a familiar script in these episodes, and the credibility of that framing is usually tested against the forward revenue guidance, net retention metrics, and any disclosure on how much of total revenue the top customer represents. The de-risked guidance language suggests the number has already been set conservatively, which in past episodes has shifted the debate from the print itself to whether the trough in that customer's usage is in sight. The follow-ons worth noting are any quantification of the concentration, commentary on remaining optimization headwinds versus new workload commitments, and how peers with similar consumption models trade in sympathy.
- OpenAI expects future AI models to be capable of identifying and exploiting vulnerabilities that are currently unknown, according to a blog post
- Texas Attorney General Ken Paxton sues OpenAI and CEO Sam Altman for lying to users and harming Texans
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL
- CrowdStrike (CRWD) CEO says in the coming months we will see a lot of breaches from the PHP vulnerability
- Oracle (ORCL) to invest USD 1bln in partner ecosystem over 4 years
Related headlines
- OpenAI reveals plans for an in-house exabyte-scale storage system12 hours ago
- Kimi K3.1 Pro AI model builds GTA VI-style (TTWO) playable game demo in just 10 hours for USD 52, developer claims on X; showcases AI’s ability to generate video game experiences - UNCONFIRMED8 hours ago
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS11 hours ago
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter12 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)13 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed13 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce14 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders14 hours ago
- Newsquawk Weekly Economic Release 26th - 30th October 2026 13 hours ago
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease8 hours ago
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 202711 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer14 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation15 hours ago
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM15 hours ago
- Bristol-Myers Squibb (BMY) says Iza-Bren reduced the risk of progression or death by 59% in Phase 3 breast cancer study; median PFS 8.2 months vs 4.0 months for chemotherapy; cORR 40.5% vs 20.2%; mDOR 6.9 vs 4.2 months16 hours ago